Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.92
+0.15 (2.60%)
At close: Nov 18, 2025, 4:00 PM EST
5.85
-0.07 (-1.17%)
After-hours: Nov 18, 2025, 5:36 PM EST
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $127.23 million as of November 18, 2025. Its market cap has increased by 152.04% in one year.
Market Cap
127.23M
Enterprise Value
80.07M
1-Year Change
152.04%
Ranking
Category
Stock Price
$5.92
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $127.23M, an increase of 91.35%. That is a compound annual growth rate of 16.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 926.78B |
| Johnson & Johnson | 480.15B |
| AbbVie | 414.63B |
| UnitedHealth Group | 281.84B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 238.30B |
| Abbott Laboratories | 225.78B |